期刊文献+

探讨早期乳腺癌前哨淋巴结活检结果的相关影响因素 被引量:3

Exploration on the Influencing Factors of Sentinel Lymph Node Biopsy in Early Breast Cancer
在线阅读 下载PDF
导出
摘要 目的:就早期乳腺癌前哨淋巴结活检结果的相关影响因素进行分析与探讨。方法:选择2014年2月~2016年1月在某院接受前哨淋巴结活检术的110例早期乳腺癌患者,分析早期乳腺癌前哨淋巴结活检结果的相关影响因素。结果:单因素筛选结果显示前哨淋巴结活检结果与病灶大小、Her-2、术前影像学腋窝评价、分子分型存在相关性(P<0.05);多因素分析结果显示病灶大小、分子分型是影响前哨淋巴结活检结果的独立因素,统计学检验均P<0.05。结论:在早期乳腺癌的临床中诊疗中,可依据病灶大小、分子分型等因素对前哨淋巴结活检结果进行预测,其中病灶较大患者、Luminal B型患者、Her-2阳性型以及三阴性乳腺癌患者的活检阳性率较高。 Objective:To analyze and discuss the related influencing factors of sentinel lymph node biopsy in early breast cancer.Methods: 110 patients with early breast cancer who underwent sentinel lymph node bi- opsy from February 2014 to January 2016 were analyzed.The influencing factors of sentinel lymph node biop- sy in early breast cancer were analyzed.Results:The results of single factor screening showed that the sentinel lymph node biopsy was correlated with lesion size, Her-2,preoperative imaging armpit evaluation and molec- ular typing,all P^0.05.Multivariate analysis showed lesion size,the independent factors that affect the out- come of sentinel lymph node biopsy were statistically significant (P ~O.05).Conclusion:In the clinical diagno- sis and treatment of early breast cancer,the results of sentinel lymph node biopsy can be predicted according to the factors such as lesion size and molecular typing.Among the patients with large lesion,Luminal B type, Her-2 positive type and triple negative mammary gland,the positive rate of biopsy in cancer patients is high.
出处 《数理医药学杂志》 2017年第5期637-639,共3页 Journal of Mathematical Medicine
关键词 早期乳腺癌 前哨淋巴结 活检结果 影响因素 early breast cancer sentinel lymph nodes biopsy results influencing factors
  • 相关文献

参考文献6

二级参考文献57

  • 1张建国,仲雷,李传乐,郭宝良,杨学伟.前哨淋巴结活检术检测乳腺癌腋窝淋巴结转移的效果评价[J].中华肿瘤杂志,2007,29(3):235-236. 被引量:4
  • 2CHEN GJ, ZHANG BN, SHAO YF, et al. The value Of sen- tinel node biopsy in the u'eaunent of breast cancer [J].Joumal of Practical Oneology, 2004,19 (3) : 226-228.
  • 3Takei H, Kurosumi M, Yoshida T, et al. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies. Breast Cancer, 2010, 17:9-16.
  • 4Taras AR, Hendrickson NA, Lowe KA, et al. Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes. Am J Surg, 2010, 199:625-625.
  • 5Pesek S, Ashikaga T, Krag LE, et al. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta- analysis. World J Surg, 2012, 36:2239-2251.
  • 6Goyal A, Newcombe RG, Chhabra A, et al. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer:results of the ALMANAC validation phase. Breast Cancer Res Treat, 2006, 99:203-208.
  • 7Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer:a muhieenter validation study. N Engl J Med, 1998, 339 : 941-946.
  • 8Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oneology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oneol, 2007, 25 : 118-145.
  • 9Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta analysis. Cancer, 2006, 106:4-16.
  • 10Javan H, Gholami H, Assadi M, et al. The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion : systematic review and meta- analysis of the literature. Eur J Surg Oncol, 2012, 38:95-109.

共引文献55

同被引文献23

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部